Skip to main content

LEMAITRE VASCULAR INC

For the period ended Mar 31, 2024. Filed May 10, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2024 · Filed May 10, 2024

LMAT$79.02-2.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Unregistered Sales of Equity Securities and Use of Proceeds

Recent Sales of Unregistered Securities

None.

Issuer Purchases of Equity Securities

Issuer Purchases of Equity Securities
Maximum Number
(or Approximate
Total Number of · Dollar Value) of
Shares (or Units) · Shares (or Units)
TotalAveragePurchased asthat may yet be
Number ofPricePart of PubliclyPurchased under
Shares (or Units)Paid PerAnnounced Plansthe Plans or
PeriodPurchased (1)Share (or Unit)or ProgramProgram
January 1, 2024 through January 31, 20243,583$55.91N/AN/A
February 1, 2024 through February 29, 20242,179$69.67N/AN/A
March 1, 2024 through March 31, 202388$67.24N/AN/A
Total5,850$61.21N/AN/A

(1) For the three months ended March 31, 2024, we repurchased 5,850 shares of our common stock to satisfy employees’ obligations with respect to minimum statutory withholding taxes in connection with the vesting of restricted stock units.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.